REG - Redcentric PLC - Director/PDMR Shareholdings

RedcentricAnnouncement

02/04/2026 13:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260402:nRSB3035Za&default-theme=true

RNS Number : 3035Z  Redcentric PLC  02 April 2026

2 April 2026

 

Redcentric plc

('Redcentric' or the 'Company')

 

Director/PDMR Shareholdings

 

Redcentric plc (AIM:RCN), a leading UK IT managed services provider, announces
that it received notification from Mr. Oliver Scott, Non-Executive Director,
that an aggregate of 61,416 ordinary shares of 0.1 pence each (all ordinary
shares in the company referred to as 'Shares') have been transferred out of
Kestrel Partners LLP's ('Kestrel') discretionary management and control due to
rearrangements of two client portfolios. These shares continue to be held by
the same beneficial owners.

 

Mr. Scott is a partner of, and holds a beneficial interest in, Kestrel. Mr.
Scott is also a shareholder in one of Kestrel's clients ('Kestrel
Opportunities') and is therefore deemed to have a beneficial interest in
Kestrel Opportunities' entire legal holding in Redcentric.

 

Following this notification, Kestrel Opportunities continues to hold (and
consequently Mr. Scott is deemed to have a beneficial interest in) 16,715,306
Ordinary Shares in the Company. Mr Scott also holds 6,089 shares in
certificated form. Other clients of Kestrel, in which Mr. Scott has no
beneficial interest, hold 15,826,624 Ordinary Shares in the Company.

 

On a combined basis, Kestrel indirectly holds voting rights over 32,548,019
Ordinary Shares in the Company, which represents approximately 20.43 per cent
of the total voting rights in the Company.

 

Kestrel's interest in the Shares in the Company is held through the following
nominees:

 

 Nominee                                   No. of Ordinary Shares      % of total

                                                                       voting rights
 Bank of New York Nominees Ltd             16,715,306                  10.49%
 JIM Nominees Limited                      19,500                      0.02%
 Bank of New York Nominees Ltd             12,485,870                  7.84%
 Northern Trust Company AVFC               3,105,436                   1.95%
 iDealing Nominees Limited                 215,818                     0.17%
 Certificated Shares held by Oliver Scott             6,089            0.00%

 

Enquiries:

 Redcentric plc

 Michelle Senecal De Fonesca, CEO                           Via Burson Buchanan

 Tony Ratcliffe, CFO                                        www.redcentricplc.com (http://www.redcentricplc.com)

 Cavendish Capital Markets Limited (NOMAD and Sole Broker)

 Marc Milmo / Callum Davidson (Corporate Finance)           Tel: +44 (0) 20 7220 0500

 Andrew Burdis / Sunila de Silva (ECM)
 For media enquiries:

 Burson Buchanan - Financial Communications                 Tel: +44 (0) 20 7466 5000 redcentric@buchanancomms.co.uk

                                                          (mailto:redcentric@buchanancomms.co.uk)
 Henry Harrison-Topham / Jamie Hooper / Toto Berger

 

ANNEX

 

Template for notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely associated with
them.

 

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Oliver Scott

 2    Reason for the notification

 a)   Position/status                                              PCA - Kestrel Partners LLP are a PCA of Oliver Scott (non-executive director

                                                            of Redcentric plc and Managing Partner of Kestrel).

 b)   Initial notification /Amendment                              Initial

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         Redcentric plc

 b)   LEI                                                          213800FGYMMNE9OKFD14

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  0.1 pence Ordinary Shares

      Identification code

                                                                   ISIN: GB00B7TW1V39
 b)   Nature of the transaction                                    Transfer of Shares out of Kestrel controlled accounts. Mr. Scott is a partner

                                                                 of, and holds a beneficial interest in, Kestrel. Mr. Scott is also a
                                                                   shareholder in one of Kestrel's clients ("Kestrel Opportunities"), and is
                                                                   therefore deemed to have a beneficial interest in Kestrel Opportunities'
                                                                   entire legal holding in Shares in Redcentric.
 c)   Price(s) and volume(s)                                       Price(s)  Volume(s)

                                                            N/A       61,416

 d)   Aggregated information

      - Aggregated volume                                          As above.

      - Price
 e)   Date of the transaction                                      31 March 2026

 f)   Place of the transaction                                     London Stock Exchange

d)

 

Aggregated information

- Aggregated volume

- Price

 

As above.

e)

 

Date of the transaction

 

31 March 2026

f)

 

Place of the transaction

London Stock Exchange

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHUUVARNVUSRAR



            Copyright 2019 Regulatory News Service, all rights reserved